Analysis for JPMorgan Nasdaq Equity Premium Income ETF
Analysis summary
JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) currently has a total score of 49 points, placing it in the neutral range. The score is made up of Performance (43), Stability (68) and Trend (35). The profile is clearly uneven: Stability stands out while Trend lags.
Performance scores 43 points (neutral). Most supportive metric: 3Y return at 33.5 %. Weaker metric: 1Y return at -1.3 %.
Stability scores 68 points (strong). Key strength: CAGR/drawdown ratio at 0.47. Main drag: return/volatility ratio at -0.07. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 35 points (weak). Trend signals are mostly negative right now. Least weak metric: trend strength at 0.37. Main drag: Price is about 2.3 % below SMA50.
Overall, the picture is mixed: Stability does the heavy lifting while Trend holds the score back. On a metric level, CAGR/drawdown ratio stands out, while SMA50 distance is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Stability
FAQ
- What investor type does JPMorgan Nasdaq Equity Premium Income ETF fit best in FoxScore?
- JPMorgan Nasdaq Equity Premium Income ETF fits a more defensive investor type in FoxScore: stability is the strongest part of the profile. That points to comparatively smaller drawdowns and calmer swings versus the universe — but prices can still fall.
- How meaningful is the available history for JPMorgan Nasdaq Equity Premium Income ETF?
- JPMorgan Nasdaq Equity Premium Income ETF currently has about 3.8 years of price history since it started trading. This lets you judge how it behaved in its market phases since launch, but long-term conclusions across multiple cycles are naturally limited.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.